Prevention of iodinated contrast-induced nephropathy

Chinese Medical Journal

Volumn 124, Issue 23, 2011, Pages 4079-4082

  Li, Jian Hua ^a   He, Neng Shu ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Contrast medium; Contrast induced nephropathy; Prevention

Indexed keywords

ACETYLCYSTEINE; ADENOSINE RECEPTOR BLOCKING AGENT; ASCORBIC ACID; ATRIAL NATRIURETIC FACTOR; CALCIUM CHANNEL BLOCKING AGENT; CYCLOOXYGENASE 2 INHIBITOR; CYCLOSPORIN A; DOPAMINE RECEPTOR STIMULATING AGENT; ENDOTHELIN RECEPTOR ANTAGONIST; ERYTHROPOIETIN; FENOLDOPAM; GENTAMICIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IODINATED CONTRAST MEDIUM; ISOTONIC SOLUTION; MANNITOL; MELATONIN; MESNA; METFORMIN; NEBIVOLOL; NEPHROTOXIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; TOXIC SUBSTANCE; TRIMETAZIDINE; UNCLASSIFIED DRUG;

ANGIOCARDIOGRAPHY; CONTRAST INDUCED NEPHROPATHY; CORONARY SINUS; DRUG MEGADOSE; DRUG WITHDRAWAL; HEMODIALYSIS; HEMOFILTRATION; HUMAN; HYDRATION; LOW DRUG DOSE; NONHUMAN; PERICATHETERIZATION HYDRATION; PROPHYLAXIS; REVIEW; RISK FACTOR;

CONTRAST MEDIA; HUMANS; IODINE; KIDNEY DISEASES;

EID: 84862954497     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.23.042     Document Type: Review

References (30)

1. Vercellino M, Bezante GP, Balbi M. Contrast medium induced nephropathy: new insights into prevention and risk management. Cardiovasc Hematol Agents Med Chem 2009; 7: 166-180.
2. Chong E, Poh KK, Shen L, Chai P, Tan HC. Diabetic patients with normal baseline renal function are at increased risk of developing contrast-induced nephropathy post-percutaneous coronary intervention. Singapore Med J 2009; 50: 250-254.
3. Chen XM, Pan XL. Risk markers for contrast induced nephropathy. China Med Herald (Chin) 2009; 6: 217-218.
4. Toprak O. Conflicting and new risk factors for contrast induced nephropathy. J Urol 2007; 178: 2277-2283.
5. Solomon RJ, Mehran R, Natarajan MK, Doucet S, Katholi RE, Staniloae CS, et al. Contrast-induced nephropathy and long-term adverse events: cause and effect? Clin J Am Soc Nephrol 2009; 4: 1162-1169.
6. Bader BD, Berger ED, Heede MB, Silberbaur I, Duda S, Risler T, et al. What is the best hydration regimen to prevent contrast media-induced nephrotoxicity? Clin Nephrol 2004; 62: 1-7.
7. Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002; 162: 329-336.
8. Weisbord SD, Palevsky PM. Prevention of contrast-induced nephropathy with volume expansion. Clin J Am Soc Nephrol 2008; 3: 273-280.
9. Marrón B, Ruiz E, Fernández C, Almeida P, Horcajada C, Navarro F, et al. Systemic and renal effects of preventing contrast nephrotoxicity with isotonic (0.9%) and hypotonic(0.45%) saline. Rev Esp Cardiol 2007; 60: 1018-1025.
10. Masuda M, Yamada T, Mine T, Morita T, Tamaki S, Tsukamoto Y, et al. Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure. Am J Cardiol 2007; 100: 781-786.
11. From AM, Bartholmai BJ, Williams AW, Cha SS, Pflueger A, McDonald FS. Sodium bicarbonate is associated with an increased incidence of contrast nephropathy: a retrospective cohort study of 7977 patients at mayo clinic. Clin J Am Soc Nephrol 2008; 3: 10-18.
12. Clavijo LC, Pinto TL, Kuchulakanti PK, Torguson R, Chu WW, Satler LF, et al. Effect of a rapid intra-arterial infusion of dextrose 5% prior to coronary angiography on frequency of contrast-induced nephropathy in high-risk patients. Am J Cardiol 2006; 97: 981-983.
13. Schweiger MJ, Chambers CE, Davidson CJ, Blankenship J, Bhalla NP, Block PC, et al. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures. Catheter Cardiovasc Interv 2007; 69: 135-140.
14. Detrenis S, Meschi M, Bertolini L, Savazzi G. Contrast medium administration in the elderly patient: is advancing age an independent risk factor for contrast nephropathy after angiographic procedures? J Vasc Interv Radiol 2007; 18: 177-185.
15. Thomsen HS. European society of urogenital radiology guidelines on contrast media application. Curr Opin Urol 2007; 17: 70-76.
16. Marenzi G, Assanelli E, Campodonico J, Lauri G, Marana I, De Metrio M, et al. Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Ann Intern Med 2009; 150: 170-177.
17. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004; 44: 1393-1399.
18. Cigarroa RG, Lange RA, Williams RH, Hillis LD. Dosing of contrast material to prevent contrast nephropathy in patientswith renal disease. Am J Med 1989; 86: 649-652.
19. Rodby RA. Preventing complications of radiographic contrast media: is there a role for dialysis? Semin Dial 2007; 20: 19-23.
20. Michishita I, Fujii Z. A novel contrast removal system from the coronary sinus using an adsorbing column during coronary angiography in a porcine model. J Am Coll Cardiol 2006; 47: 1866-1870.
21. Meyer M, Dauerman HL, Bell SP, Lewinter MM, Lustgarten DL. Coronary venous capture of contrast during angiography. J Interv Cardiol 2006; 19: 401-404.
22. Danenberg HD, Lotan C, Varshitski B, Rosenheck S, Weiss AT. Removal of contrast medium from the coronary sinus during coronary angiography: feasibility of a simple and available technique for the prevention of nephropathy. Cardiovasc Revasc Med 2008; 9: 9-13.
23. Guastoni C, De Servi S. Pathophysiology of contrast-induced nephropathy. Ital Cardiol (Rome) 2009; 10: 73-78.
24. Haeussler U, Riedel M, Keller F. Free reactive oxygen species and nephrotoxicity of contrast agents. Kidney Blood Press Res 2004; 27: 167-171.
25. Onbasili AO, Yeniceriglu Y, Agaoglu P, Karul A, Tekten T, Akar H, et al. Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures. Heart 2007; 93: 698-702.
26. Gazi S, Altun A, Erdogan O. Contrast-induced nephropathy: preventive and protective effects of melatonin. J Pineal Res 2006; 41: 53-57.
27. Goldfarb M, Rosenberger C, Ahuva S, Rosen S, Heyman SN. A role for erythropoietin in the attenuation of radiocontrastinduced acute renal failure in rats. Ren Fail 2006; 28: 345-350.
28. Yokomaku Y, Sugimoto T, Kume S, Araki S, Isshiki K, Chin-Kanasaki M, et al. Asialoerythropoietin prevents contrast-induced nephropathy. J Am Soc Nephrol 2008; 19: 321-328.
29. Allie DE, Lirtzman MD, Wyatt CH, Keller VA, Mitran EV, Hebert CJ, et al. Targeted renal therapy and contrast-induced nephropathy during endovascular abdominal aortic aneurysm repair: results of a feasibility pilot trial. J Endovasc Ther 2007; 14: 520-527.
30. Toprak O, Cirit M, Tanrisev M, Yazici C, Canoz O, Sipahioglu M, et al. Preventive effect of nebivolol on contrast-induced nephropathy in rats. Nephrol Dial Transplant 2008; 23: 853-859.